Bayesian Capital Management’s Eastman Chemical EMN Stock Holding History

Bayesian Capital Management’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,218	Closed	-$1.43M	–	638
2025 Q1	$1.43M	Buy	+16,218	New	+$1.53M	0.24%	122
2024 Q1	–	Sell	-3,946	Closed	-$354K	–	865
2023 Q4	$354K	Buy	+3,946	New	+$315K	0.04%	460
2023 Q3	–	Sell	-24,287	Closed	-$2.03M	–	780
2023 Q2	$2.03M	Buy	+24,287	New	+$1.97M	0.22%	122
2022 Q3	–	Sell	-3,500	Closed	-$314K	–	784
2022 Q2	$314K	Buy	+3,500	New	+$362K	0.06%	465
2018 Q3	–	Sell	-13,500	Closed	-$1.35M	–	672
2018 Q2	$1.35M	Buy	+13,500	New	+$1.43M	0.3%	79
2017 Q1	–	Sell	-18,215	Closed	-$1.37M	–	484
2016 Q4	$1.37M	Buy	+18,215	New	+$1.32M	0.34%	72

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bayesian Capital Management's EMN Position: Q2 2025 in Review

Bayesian Capital Management sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 16,218 shares — an estimated $1.43M sold.

Bayesian Capital Management first reported a position in EMN in Q4 2016 and held it in 6 quarters. The position peaked at $2.03M in Q2 2023. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2025.

Bayesian Capital Management reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 16,218 Eastman Chemical shares in Q2 2025, an estimated $1.43M.
Bayesian Capital Management first reported a position in Eastman Chemical in Q4 2016 and held it in 6 quarters.
Bayesian Capital Management's Eastman Chemical position peaked at $2.03M in Q2 2023.
751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.